CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | p-menthadiene |
|
Accession: | CHEBI:50073
|
browse the term
|
Definition: | A monoterpene that consists of an unsaturated p-menthane skeleton having two double bonds. |
Synonyms: | related_synonym: | Formula=C10H16 |
|
|
|
G |
Aatf |
apoptosis antagonizing transcription factor |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of AATF mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ACP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ACSS2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Adam18 |
ADAM metallopeptidase domain 18 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ADAM18 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:67,352,360...67,425,820
Ensembl chr16:67,352,416...67,425,248
|
|
G |
Adam3a |
ADAM metallopeptidase domain 3A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ADAM3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:67,299,949...67,349,970
Ensembl chr16:67,299,949...67,349,968
|
|
G |
Afg2a |
AFG2 AAA ATPase homolog A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of AFG2A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:120,306,417...120,497,707
Ensembl chr 2:120,306,412...120,497,705
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of AKT1 protein |
CTD |
PMID:25649747 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
increases expression |
ISO |
alpha phellandrene results in increased expression of ALDOC mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Ankrd49 |
ankyrin repeat domain 49 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ANKRD49 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:11,627,512...11,632,200
Ensembl chr 8:11,627,518...11,632,207
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ANXA1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa9 |
annexin A9 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ANXA9 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374
|
|
G |
Ap3m2 |
adaptor related protein complex 3 subunit mu 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of AP3M2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ARG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgef12 |
Rho guanine nucleotide exchange factor 12 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ARHGEF12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366
|
|
G |
Arsk |
arylsulfatase family, member K |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ARSK mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467
|
|
G |
Aspa |
aspartoacylase |
increases expression |
ISO |
alpha phellandrene results in increased expression of ASPA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ATF3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases phosphorylation |
ISO |
alpha phellandrene results in increased phosphorylation of BCL2 protein |
CTD |
PMID:25649747 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
increases phosphorylation |
ISO |
alpha phellandrene results in increased phosphorylation of BECN1 protein |
CTD |
PMID:25649747 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bmf |
Bcl2 modifying factor |
increases expression |
ISO |
alpha phellandrene results in increased expression of BMF mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of BNIP3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bod1 |
biorientation of chromosomes in cell division 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of BOD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:15,993,454...15,999,795
Ensembl chr10:15,993,454...15,999,787
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of BRCA1 protein |
CTD |
PMID:24861204 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of BTG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Calm2 |
calmodulin 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CALM2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
|
|
G |
Capns1 |
calpain, small subunit 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CAPNS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
|
|
G |
Caprin2 |
caprin family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CAPRIN2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830
|
|
G |
Card6 |
caspase recruitment domain family, member 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CARD6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:54,194,343...54,206,902
Ensembl chr 2:54,195,739...54,206,846
|
|
G |
Carhsp1 |
calcium regulated heat stable protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CARHSP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CCL5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccng2 |
cyclin G2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CCNG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CCRL2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Cd59b |
CD59b molecule |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CD59A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cdcp2 |
CUB domain containing protein 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CDCP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:121,877,581...121,894,203
Ensembl chr 5:121,877,581...121,894,203
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
alpha phellandrene results in increased expression of CDKN1A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
increases expression |
ISO |
alpha phellandrene results in increased expression of CDKN2D mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
alpha phellandrene results in increased expression of CFLAR mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLEC12A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Clec4d |
C-type lectin domain family 4, member D |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLEC4D mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
|
|
G |
Clec6a-ps1 |
C-type lectin domain family 6, member A, pseudogene 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLEC4N mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:156,539,408...156,559,032
Ensembl chr 4:156,539,408...156,558,605 Ensembl chr 4:156,539,408...156,558,605
|
|
G |
Cluh |
clustered mitochondria homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLUH mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:59,509,580...59,531,345
Ensembl chr10:59,509,726...59,531,345
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CMPK2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cr1l |
complement C3b/C4b receptor 1 like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CR1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:106,606,952...106,660,442
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Crisp1 |
cysteine-rich secretory protein 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CRISP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:20,741,775...20,768,796
Ensembl chr 9:20,741,777...20,768,796
|
|
G |
Cst7 |
cystatin F |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CST7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
|
|
G |
Csta |
cystatin A |
increases expression |
ISO |
alpha phellandrene results in increased expression of STFA1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Ctsg |
cathepsin G |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CTSG mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CXCL10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyb561d2 |
cytochrome b561 family, member D2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CYB561D2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:108,213,201...108,215,778
Ensembl chr 8:108,213,205...108,215,759
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CYFIP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CYP51 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
|
|
G |
Dbx1 |
developing brain homeobox 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DBX1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:99,348,638...99,354,173
Ensembl chr 1:99,349,608...99,354,038
|
|
G |
Dctd |
dCMP deaminase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DCTD mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:44,066,952...44,098,654
Ensembl chr16:44,055,128...44,098,446
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DDIT4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddx31 |
DEAD-box helicase 31 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DDX31 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:12,172,829...12,238,392
Ensembl chr 3:12,172,836...12,238,873
|
|
G |
Ddx60 |
DEXD/H-box helicase 60 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DDX60 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
increases expression |
ISO |
alpha phellandrene results in increased expression of DFFB mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dgka |
diacylglycerol kinase, alpha |
increases expression |
ISO |
alpha phellandrene results in increased expression of DGKA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110
|
|
G |
Dhrs1 |
dehydrogenase/reductase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DHRS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838
|
|
G |
Dhx33 |
DEAH-box helicase 33 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DHX33 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:55,708,102...55,724,618
Ensembl chr10:55,705,756...55,724,567
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DHX58 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DKC1 mRNA |
CTD |
PMID:25075043 |
|
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DUSP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DUSP6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DYNLT3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of EGLN3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of EGR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of EIF5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
|
|
G |
Elac2 |
elaC ribonuclease Z 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ELAC2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ELOVL1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
|
|
G |
Elovl7 |
ELOVL fatty acid elongase 7 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ELOVL7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ENO2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Fbxo44 |
F-box protein 44 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FBXO44 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:158,583,363...158,592,510
Ensembl chr 5:158,583,366...158,592,363
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
increases expression |
ISO |
alpha phellandrene results in increased expression of FGGY mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
|
|
G |
Flvcr1 |
FLVCR choline and heme transporter 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FLVCR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:102,586,263...102,608,647
Ensembl chr13:102,586,257...102,608,661
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
alpha phellandrene results in increased expression of FOS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FOXO1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fpr1 |
formyl peptide receptor 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FPR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:58,747,246...58,756,559
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FTH1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Ftsj3 |
FtsJ RNA 2'-O-methyltransferase 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FTSJ3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:91,180,945...91,187,389
Ensembl chr10:91,180,696...91,187,397
|
|
G |
Fxn |
frataxin |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FXN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
|
|
G |
Gabarap |
GABA type A receptor-associated protein |
increases expression |
ISO |
alpha phellandrene results in increased expression of GABARAP mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
alpha phellandrene results in increased expression of GADD45A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GAS5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gbp6 |
guanylate binding protein family member 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GBP6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
|
|
G |
Gnas |
GNAS complex locus |
increases expression |
ISO |
alpha phellandrene results in increased expression of GNAS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnl3 |
G protein nucleolar 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GNL3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:6,207,402...6,213,491
Ensembl chr16:6,207,402...6,213,392
|
|
G |
Gpr84 |
G protein-coupled receptor 84 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GPR84 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
|
|
G |
Greb1l |
GREB1 like retinoic acid receptor coactivator |
increases expression |
ISO |
alpha phellandrene results in increased expression of GREB1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:1,392,330...1,629,483
Ensembl chr18:1,392,725...1,628,067
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GRINA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GTDC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:28,766,640...29,161,668
Ensembl chr 3:28,766,645...29,162,271
|
|
G |
Gys1 |
glycogen synthase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GYS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
|
|
G |
Gzmf |
granzyme F |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GZME mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:30,005,361...30,018,649
Ensembl chr15:30,007,267...30,018,649
|
|
G |
H1f0 |
H1.0 linker histone |
increases expression |
ISO |
alpha phellandrene results in increased expression of H1F0 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
increases expression |
ISO |
alpha phellandrene results in increased expression of H1F2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
|
|
G |
H2bc18 |
H2B clustered histone 18 |
increases expression |
ISO |
alpha phellandrene results in increased expression of H2BC18 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529
|
|
G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HCAR2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504
|
|
G |
Heatr1 |
HEAT repeat containing 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of HEATR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
|
|
G |
Helz2 |
helicase with zinc finger 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HELZ2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Hgh1 |
HGH1 homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of BRP16 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:108,091,918...108,094,740
Ensembl chr 7:108,091,951...108,094,737
|
|
G |
Hilpda |
hypoxia inducible lipid droplet-associated |
increases expression |
ISO |
alpha phellandrene results in increased expression of HILPDA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
|
|
G |
Hivep3 |
HIVEP zinc finger 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HIVEP3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HSPA2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of HSPA5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of HSPA8 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ID2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of IDI1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IFIH1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
|
|
G |
Ifnl3 |
interferon, lambda 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IFNL3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of IL2RA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il36g |
interleukin 36, gamma |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of IL36G mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
|
|
G |
Irf5 |
interferon regulatory factor 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IRF5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
|
|
G |
Irf7 |
interferon regulatory factor 7 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IRF7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irgm |
immunity-related GTPase M |
increases expression |
ISO |
alpha phellandrene results in increased expression of IRGM2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Itgal |
integrin subunit alpha L |
increases expression |
ISO |
alpha phellandrene results in increased expression of ITGAL mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Jagn1 |
jagunal homolog 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of JAGN1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:146,591,577...146,596,287
Ensembl chr 4:146,591,510...146,596,288
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
alpha phellandrene results in increased expression of JUN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kank2 |
KN motif and ankyrin repeat domains 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of KANK2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900
|
|
G |
Kdm7a |
lysine demethylase 7A |
increases expression |
ISO |
alpha phellandrene results in increased expression of KDM7A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998
|
|
G |
Klhl24 |
kelch-like family member 24 |
increases expression |
ISO |
alpha phellandrene results in increased expression of KLHL24 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of LIMA1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Llgl2 |
LLGL scribble cell polarity complex component 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of LLGL2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:101,050,978...101,086,527
Ensembl chr10:101,051,408...101,086,525
|
|
G |
LOC120098677 |
small nucleolar RNA MBII-202 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD68 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr19:51,154,626...51,154,708
Ensembl chr19:51,154,626...51,154,708
|
|
G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
increases expression |
ISO |
alpha phellandrene results in increased expression of LPP mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
|
|
G |
Ltn1 |
listerin E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of LTN1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886
|
|
G |
Ly6h |
lymphocyte antigen 6 family member H |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:107,258,779...107,261,270
Ensembl chr 7:107,258,779...107,261,454
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MAP2K6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MAT2A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
|
|
G |
Mcemp1 |
mast cell-expressed membrane protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MCEMP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:1,721,781...1,727,350
Ensembl chr12:1,718,730...1,725,986
|
|
G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MDC1 protein |
CTD |
PMID:24861204 |
|
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
|
|
G |
Mdn1 |
midasin AAA ATPase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MDN1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332
|
|
G |
Med29 |
mediator complex subunit 29 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MED29 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
|
|
G |
Med31 |
mediator complex subunit 31 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MED31 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326
|
|
G |
Mgarp |
mitochondria-localized glutamic acid-rich protein |
increases expression |
ISO |
alpha phellandrene results in increased expression of MGARP mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
|
|
G |
Mgat2 |
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MGAT2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MGMT protein |
CTD |
PMID:24861204 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mindy2 |
MINDY lysine 48 deubiquitinase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MINDY2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453
|
|
G |
Mir375 |
microRNA 375 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MIR375 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985
|
|
G |
Mr1 |
major histocompatibility complex, class I-related |
increases expression |
ISO |
alpha phellandrene results in increased expression of MR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MRPL20 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
|
|
G |
Mrpl45 |
mitochondrial ribosomal protein L45 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MRPL45 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:82,308,650...82,320,474
Ensembl chr10:82,308,427...82,320,474
|
|
G |
Mrto4 |
MRT4 homolog, ribosome maturation factor |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MRTO4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:151,601,780...151,608,533
Ensembl chr 5:151,601,780...151,608,287
|
|
G |
Ms4a3 |
membrane spanning 4-domains A3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MS4A3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:208,462,300...208,480,129
Ensembl chr 1:208,462,301...208,480,101
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MTOR protein |
CTD |
PMID:25649747 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtx3 |
metaxin 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MTX3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:24,066,332...24,079,708
Ensembl chr 2:24,066,365...24,079,670
|
|
G |
Muc13 |
mucin 13, cell surface associated |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MUC13 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727
|
|
G |
Mx2 |
MX dynamin like GTPase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MX2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342
|
|
G |
Mxd1 |
max dimerization protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MXD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Myadm |
myeloid-associated differentiation marker |
increases expression |
ISO |
alpha phellandrene results in increased expression of MYADM mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
|
|
G |
Mybbp1a |
MYB binding protein 1a |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MYBBP1A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:57,056,897...57,067,258
Ensembl chr10:57,056,874...57,067,255
|
|
G |
Myo9a |
myosin IXA |
increases expression |
ISO |
alpha phellandrene results in increased expression of MYO9A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
increases expression |
ISO |
alpha phellandrene results in increased expression of NAMPT mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nat10 |
N-acetyltransferase 10 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NAT10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:90,111,643...90,149,891
Ensembl chr 3:90,111,645...90,149,927
|
|
G |
Ndrg2 |
NDRG family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of NDRG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
increases expression |
ISO |
alpha phellandrene results in increased expression of NFIL3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases expression |
ISO |
alpha phellandrene results in increased expression of NFKBIA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nhp2 |
NHP2 ribonucleoprotein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NHP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
|
|
G |
Nol10 |
nucleolar protein 10 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOL10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:40,144,217...40,225,353
Ensembl chr 6:40,144,235...40,225,353
|
|
G |
Nol8 |
nucleolar protein 8 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOL8 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848
|
|
G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOLC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088
|
|
G |
Nop2 |
NOP2 nucleolar protein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:157,932,731...157,944,462
Ensembl chr 4:157,932,716...157,944,459
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOP56 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of NOS2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nxt2 |
nuclear transport factor 2-like export factor 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of NXT2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:105,855,616...105,862,902
Ensembl chr X:105,855,608...105,862,899
|
|
G |
Oas1a |
2'-5' oligoadenylate synthetase 1A |
increases expression |
ISO |
alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
|
|
G |
Oas3 |
2'-5'-oligoadenylate synthetase 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of OAS3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
|
|
G |
Osbpl9 |
oxysterol binding protein-like 9 |
increases expression |
ISO |
alpha phellandrene results in increased expression of OSBPL9 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196
|
|
G |
Pabir2 |
PABIR family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PABIR2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:132,989,124...133,015,625
Ensembl chr X:132,989,124...133,015,580
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PARP14 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Pcyox1l |
prenylcysteine oxidase 1 like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PCYOX1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
|
|
G |
Pde3b |
phosphodiesterase 3B |
increases expression |
ISO |
alpha phellandrene results in increased expression of PDE3B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334
|
|
G |
Phospho1 |
phosphoethanolamine/phosphocholine phosphatase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PHOSPHO1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
increases expression |
ISO |
alpha phellandrene results in increased expression of PIK3CB mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Pld4 |
phospholipase D family, member 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PLD4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376
|
|
G |
Plxdc1 |
plexin domain containing 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PLXDC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130
|
|
G |
Pnrc2 |
proline-rich nuclear receptor coactivator 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PNRC2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:148,103,966...148,106,950
Ensembl chr 5:148,095,699...148,107,242 Ensembl chr 5:148,095,699...148,107,242
|
|
G |
Polr1b |
RNA polymerase I subunit B |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of POLR1B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:116,333,910...116,358,385
Ensembl chr 3:116,333,889...116,358,379
|
|
G |
Pop1 |
POP1 homolog, ribonuclease P/MRP subunit |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of POP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141
|
|
G |
Ppan |
peter pan homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PPAN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PPAT mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144
|
|
G |
Ppm1k |
protein phosphatase, Mg2+/Mn2+ dependent, 1K |
increases expression |
ISO |
alpha phellandrene results in increased expression of PPM1K mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152
|
|
G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
increases expression |
ISO |
alpha phellandrene results in increased expression of PPP2R5C mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:129,461,689...129,598,344
Ensembl chr 6:129,461,648...129,598,346
|
|
G |
Pprc1 |
PPARG related coactivator 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PPRC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PRKDC protein |
CTD |
PMID:24861204 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Prss1 |
serine protease 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TRY10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792
|
|
G |
Ptbp3 |
polypyrimidine tract binding protein 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PTBP3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:74,313,367...74,399,439
Ensembl chr 5:74,315,101...74,399,791
|
|
G |
Ptpmt1 |
protein tyrosine phosphatase, mitochondrial 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PTPMT1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:76,889,922...76,899,427
Ensembl chr 3:76,889,922...76,899,427
|
|
G |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PTPN7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:46,570,904...46,584,048
Ensembl chr13:46,571,712...46,583,308
|
|
G |
Pus7 |
pseudouridine synthase 7 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PUS7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:11,360,169...11,401,139
Ensembl chr 4:11,360,188...11,401,172
|
|
G |
Pus7l |
pseudouridine synthase 7 like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PUS7L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:125,659,507...125,706,582
Ensembl chr 7:125,659,507...125,682,333
|
|
G |
Rad51c |
RAD51 paralog C |
increases expression |
ISO |
alpha phellandrene results in increased expression of RAD51C mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248
|
|
G |
Rap2b |
RAP2B, member of RAS oncogene family |
increases expression |
ISO |
alpha phellandrene results in increased expression of RAP2B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:145,599,714...145,600,265
Ensembl chr 2:145,599,116...145,603,069
|
|
G |
Rbm12b |
RNA binding motif protein 12B |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RBM12B2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:25,597,405...25,610,324
Ensembl chr 5:25,590,493...25,611,245
|
|
G |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
increases expression |
ISO |
alpha phellandrene results in increased expression of RBPJ mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353
|
|
G |
Rcl1 |
RNA terminal phosphate cyclase-like 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RCL1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
|
|
G |
RGD1359108 |
similar to RIKEN cDNA 3110043O21 |
increases expression |
ISO |
alpha phellandrene results in increased expression of C9ORF72 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:49,766,340...49,791,434
Ensembl chr 5:49,766,325...49,791,408
|
|
G |
Rhobtb2 |
Rho-related BTB domain containing 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RHOBTB2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:44,868,251...44,888,436
Ensembl chr15:44,870,376...44,888,651
|
|
G |
Rig1 |
RNA sensor RIG-1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RIGI mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
|
|
G |
rnf141 |
ring finger protein 141 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RNF141 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:164,933,972...164,957,081
Ensembl chr 1:164,931,077...164,957,118
|
|
G |
Rnf19b |
ring finger protein 19B |
increases expression |
ISO |
alpha phellandrene results in increased expression of RNF19B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
|
|
G |
Rp2 |
RP2 activator of ARL3 GTPase |
increases expression |
ISO |
alpha phellandrene results in increased expression of RP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688
|
|
G |
Rpp14 |
ribonuclease P/MRP subunit p14 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RPP14 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:16,837,796...16,847,970
Ensembl chr15:16,836,859...16,852,101 Ensembl chr15:16,836,859...16,852,101
|
|
G |
Rpp38 |
ribonuclease P/MRP subunit p38 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RPP38 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:74,914,066...74,917,742
Ensembl chr17:74,908,932...74,927,431
|
|
G |
Rps12 |
ribosomal protein S12 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RPS12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
|
|
G |
Rras |
RAS related |
increases expression |
ISO |
alpha phellandrene results in increased expression of RRAS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
|
|
G |
Rrp12 |
ribosomal RNA processing 12 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RRP12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:240,672,378...240,705,992
Ensembl chr 1:240,672,382...240,706,018
|
|
G |
Rrp15 |
ribosomal RNA processing 15 homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RRP15 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:98,276,276...98,299,357
Ensembl chr13:98,276,134...98,299,370
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RSAD2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Rtl1 |
retrotransposon-like 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RTL1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:128,543,904...128,549,384
Ensembl chr 6:128,543,939...128,549,182
|
|
G |
Rtl8a |
retrotransposon Gag like 8A |
increases expression |
ISO |
alpha phellandrene results in increased expression of RTL8A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240
|
|
G |
Rtp4 |
receptor (chemosensory) transporter protein 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RTP4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
|
|
G |
Rubcnl |
rubicon like autophagy enhancer |
increases expression |
ISO |
alpha phellandrene results in increased expression of RUBCNL mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:50,332,458...50,377,494
Ensembl chr15:50,332,418...50,400,849
|
|
G |
Samhd1 |
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SAMHD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SAT1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Sdad1 |
SDA1 domain containing 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SDAD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:15,741,489...15,768,271
Ensembl chr14:15,741,434...15,771,066
|
|
G |
Sec14l1 |
SEC14-like lipid binding 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SEC14L1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
|
|
G |
Selenbp1 |
selenium binding protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
G |
Sema3c |
semaphorin 3C |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SEMA3C mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
|
|
G |
Senp2 |
SUMO specific peptidase 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SENP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238
|
|
G |
Septin8 |
septin 8 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SEPT8 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:37,684,649...37,713,704
Ensembl chr10:37,684,639...37,713,174
|
|
G |
Sertad3 |
SERTA domain containing 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SERTAD3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001
|
|
G |
Set |
Set nuclear proto-oncogene |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SET mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
alpha phellandrene results in increased expression of SFN protein |
CTD |
PMID:24861204 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sgf29 |
SAGA complex associated factor 29 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SGF29 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:181,238,458...181,271,931
Ensembl chr 1:181,238,468...181,274,781
|
|
G |
Sgo2 |
shugoshin 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SGO2A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SIGMAR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc35b1 |
solute carrier family 35, member B1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC35B1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274
|
|
G |
Slc35d1 |
solute carrier family 35 member D1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC35D1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:117,928,628...117,981,289
Ensembl chr 5:117,934,352...117,981,311
|
|
G |
Slc44a1 |
solute carrier family 44 member 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SLC44A1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:68,061,941...68,241,912
Ensembl chr 5:68,063,618...68,241,909
|
|
G |
Slc44a3 |
solute carrier family 44, member 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SLC44A3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044
|
|
G |
Slc7a1 |
solute carrier family 7 member 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC7A1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC7A11 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a6 |
solute carrier family 7 member 6 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC7A6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr19:34,073,472...34,100,268
Ensembl chr19:34,074,286...34,100,268
|
|
G |
Slfn5 |
schlafen family member 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
|
|
G |
Smim14 |
small integral membrane protein 14 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SMIM14 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760
|
|
G |
Smox |
spermine oxidase |
increases expression |
ISO |
alpha phellandrene results in increased expression of SMOX mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710 Ensembl chr X:118,731,900...118,765,710
|
|
G |
Snora20 |
small nucleolar RNA, H/ACA box 20 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA20 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:47,830,540...47,830,669
Ensembl chr 8:71,142,787...71,142,916
|
|
G |
Snora21 |
small nucleolar RNA, H/ACA box 21 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA21 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:82,775,114...82,775,249
Ensembl chr10:82,775,114...82,775,249
|
|
G |
Snora26 |
small nucleolar RNA, H/ACA box 26 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA26 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:34,127,640...34,127,760
Ensembl chr14:34,127,640...34,127,760
|
|
G |
Snora3A |
small nucleolar RNA, H/ACA box 3A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:163,540,664...163,540,793
Ensembl chr 1:163,540,664...163,540,793
|
|
G |
Snora44 |
small nucleolar RNA, H/ACA box 44 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA44 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:126,415,989...126,416,119
Ensembl chr 4:126,415,989...126,416,119
|
|
G |
Snora61 |
small nucleolar RNA, H/ACA box 61 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA61 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:144,506,420...144,506,549
Ensembl chr 5:144,506,420...144,506,549
|
|
G |
Snora73b |
small nucleolar RNA, H/ACA box 73b |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA73B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:144,545,179...144,545,382
Ensembl chr 5:144,545,179...144,545,382
|
|
G |
Snora75 |
small nucleolar RNA, H/ACA box 75 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA75 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:87,000,248...87,000,384
Ensembl chr 9:87,000,248...87,000,384
|
|
G |
Snord22 |
small nucleolar RNA, C/D box 22 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD22 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
|
|
G |
Snord34 |
small nucleolar RNA, C/D box 34 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD34 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:115,045,817...115,045,883
Ensembl chr 8:115,045,817...115,045,883
|
|
G |
Snord52 |
small nucleolar RNA, C/D box 52 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD52 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:3,878,412...3,878,477
Ensembl chr20:3,878,412...3,878,477
|
|
G |
Snord82 |
small nucleolar RNA, C/D box 82 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD82 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:87,004,515...87,004,586
Ensembl chr 9:87,004,515...87,004,586
|
|
G |
Snord87 |
small nucleolar RNA, C/D box 87 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD87 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:9,297,489...9,297,573
Ensembl chr 5:9,297,489...9,297,573
|
|
G |
Snord95 |
small nucleolar RNA, C/D box 95 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD95 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:33,171,983...33,172,050
Ensembl chr10:33,171,983...33,172,050
|
|
G |
Snord96a |
small nucleolar RNA, C/D box 96A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD96A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:33,171,093...33,171,172
Ensembl chr10:33,171,093...33,171,172
|
|
G |
Snrpd2 |
small nuclear ribonucleoprotein D2 polypeptide |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNRPD2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351 Ensembl chr20:78,798,377...78,803,351
|
|
G |
Sp100 |
SP100 nuclear antigen |
increases expression |
ISO |
alpha phellandrene results in increased expression of SP100 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
|
|
G |
Sp140 |
SP140 nuclear body protein |
increases expression |
ISO |
alpha phellandrene results in increased expression of SP140 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:86,224,472...86,274,724
Ensembl chr 9:86,224,513...86,274,542
|
|
G |
Spc25 |
SPC25 component of NDC80 kinetochore complex |
increases expression |
ISO |
alpha phellandrene results in increased expression of SPC25 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
|
|
G |
Spred3 |
sprouty-related, EVH1 domain containing 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SPRED3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:84,458,779...84,470,425
Ensembl chr 1:84,459,314...84,470,249
|
|
G |
Sri |
sorcin |
increases expression |
ISO |
alpha phellandrene results in increased expression of SRI mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
|
|
G |
Srm |
spermidine synthase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SRM mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srr |
serine racemase |
increases expression |
ISO |
alpha phellandrene results in increased expression of SRR mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
|
|
G |
Srsf7 |
serine and arginine rich splicing factor 7 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SRSF7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
|
|
G |
Ssr4 |
signal sequence receptor subunit 4 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SSR4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:151,524,191...151,528,218
Ensembl chr X:151,524,009...151,528,202
|
|
G |
St8sia5 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ST8SIA5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:70,736,395...70,802,537
Ensembl chr18:70,736,602...70,797,789
|
|
G |
Stard3nl |
STARD3 N-terminal like |
increases expression |
ISO |
alpha phellandrene results in increased expression of STARD3NL mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:45,583,278...45,617,226
Ensembl chr17:45,583,266...45,617,226
|
|
G |
Stard5 |
StAR-related lipid transfer domain containing 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of STARD5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:137,606,151...137,616,017
Ensembl chr 1:137,606,177...137,616,469
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of STAT1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of STAT2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
G |
Supv3l1 |
Suv3 like RNA helicase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SUPV3L1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:30,378,542...30,399,076
Ensembl chr20:30,378,550...30,399,054
|
|
G |
Taf1d |
TATA-box binding protein associated factor, RNA polymerase I subunit D |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TAF1D mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TBXAS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
|
|
G |
Tceanc |
transcription elongation factor A N-terminal and central domain containing |
increases expression |
ISO |
alpha phellandrene results in increased expression of TCEANC mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:27,952,539...27,961,038
Ensembl chr X:27,952,457...27,960,940
|
|
G |
Tcp11l2 |
t-complex 11 like 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TCP11L2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095
|
|
G |
Tctn3 |
tectonic family member 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TCTN3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:239,414,003...239,425,273
Ensembl chr 1:239,415,203...239,425,272
|
|
G |
Tdrd7 |
tudor domain containing 7 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TDRD7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544
|
|
G |
Tepsin |
TEPSIN, adaptor related protein complex 4 accessory protein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TEPSIN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:105,373,939...105,381,310
Ensembl chr10:105,373,941...105,382,266
|
|
G |
Tesk2 |
testis associated actin remodelling kinase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TESK2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:130,178,715...130,270,594
Ensembl chr 5:130,185,033...130,271,292
|
|
G |
Tfap4 |
transcription factor AP-4 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TFAP4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:11,001,338...11,019,386
Ensembl chr10:11,002,911...11,019,386
|
|
G |
Thg1l |
tRNA-histidine guanylyltransferase 1-like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of THG1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:30,387,929...30,396,579
Ensembl chr10:30,387,940...30,396,687
|
|
G |
Timm10 |
translocase of inner mitochondrial membrane 10 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TIMM10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940
|
|
G |
Tmem120a |
transmembrane protein 120A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TMEM120A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:20,942,243...20,950,908
Ensembl chr12:20,942,439...20,990,316
|
|
G |
Tmem97 |
transmembrane protein 97 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TMEM97 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
|
|
G |
Tmsb10 |
thymosin, beta 10 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TMSB10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
|
|
G |
Tmsb4x |
thymosin beta 4, X-linked |
increases expression |
ISO |
alpha phellandrene results in increased expression of TMSB4X mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667 Ensembl chr10:27,128,610...27,146,667
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression increases phosphorylation affects localization increases expression |
ISO |
alpha phellandrene results in decreased expression of TRP53 protein alpha phellandrene results in increased phosphorylation of TRP53 protein alpha phellandrene affects the localization of TP53 protein alpha phellandrene results in increased expression of TRP53 protein modified form |
CTD |
PMID:24861204 PMID:25649747 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpd52 |
tumor protein D52 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TPD52 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622
|
|
G |
Tpm4 |
tropomyosin 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TPM4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
|
|
G |
Trim21 |
tripartite motif-containing 21 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TRIM21 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440
|
|
G |
Tspoap1 |
TSPO associated protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TSPOAP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
|
|
G |
Tsr1 |
TSR1, ribosome maturation factor |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TSR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864
|
|
G |
Tstd3 |
thiosulfate sulfurtransferase like domain containing 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TSTD3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:35,294,652...35,304,093
Ensembl chr 5:35,294,645...35,304,101
|
|
G |
Ttc27 |
tetratricopeptide repeat domain 27 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TTC27 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:20,558,756...20,702,126
Ensembl chr 6:20,558,756...20,702,115
|
|
G |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of UBASH3A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:9,291,471...9,334,685
Ensembl chr20:9,292,139...9,329,224
|
|
G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
increases expression |
ISO |
alpha phellandrene results in increased expression of UBE2H mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:58,834,674...58,930,156
Ensembl chr 4:58,834,674...58,930,156
|
|
G |
Urb2 |
URB2 ribosome biogenesis homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of URB2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr19:52,011,019...52,036,607
Ensembl chr19:52,011,112...52,036,597
|
|
G |
Usp18 |
ubiquitin specific peptidase 18 |
increases expression |
ISO |
alpha phellandrene results in increased expression of USP18 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
|
|
G |
Usp22 |
ubiquitin specific peptidase 22 |
increases expression |
ISO |
alpha phellandrene results in increased expression of USP22 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:45,828,619...45,855,468
Ensembl chr10:45,828,622...45,855,497
|
|
G |
Usp36 |
ubiquitin specific peptidase 36 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of USP36 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:103,497,349...103,528,877
Ensembl chr10:103,497,349...103,528,877
|
|
G |
Utp20 |
UTP20 small subunit processome component |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of UTP20 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:23,134,630...23,215,639
Ensembl chr 7:23,134,637...23,215,632
|
|
G |
Wdr12 |
WD repeat domain 12 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469
|
|
G |
Wdr3 |
WD repeat domain 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:187,505,816...187,528,432
Ensembl chr 2:187,505,816...187,528,432
|
|
G |
Wdr74 |
WD repeat domain 74 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR74 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:205,631,769...205,636,558
Ensembl chr 1:205,631,824...205,636,563
|
|
G |
Wdr75 |
WD repeat domain 75 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR75 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:47,903,214...47,933,399
Ensembl chr 9:47,903,200...47,933,399
|
|
G |
Wdsub1 |
WD repeat, sterile alpha motif and U-box domain containing 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of WDSUB1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:44,340,415...44,370,890
Ensembl chr 3:44,340,415...44,370,891
|
|
G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of WIPI1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
|
|
G |
Xaf1 |
XIAP associated factor 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of XAF1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
|
|
G |
Yars2 |
tyrosyl-tRNA synthetase 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of YARS2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:84,632,350...84,638,138
Ensembl chr11:84,624,369...84,638,125
|
|
G |
Zbp1 |
Z-DNA binding protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ZBP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870
|
|
G |
Zfp26 |
zinc finger protein 26 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ZFP882 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:18,959,656...18,985,647
Ensembl chr 8:18,965,271...18,988,325
|
|
G |
Zfp260 |
zinc finger protein 260 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ZFP260 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:85,336,567...85,349,896
Ensembl chr 1:85,336,618...85,350,067
|
|
G |
Zfp346 |
zinc finger protein 346 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ZFP346 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:9,493,787...9,523,681
Ensembl chr17:9,493,803...9,523,635
|
|
G |
Zfp39 |
zinc finger protein 39 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ZFP719 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:43,656,444...43,679,743
Ensembl chr10:43,656,444...43,679,743
|
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
perillyl alcohol results in increased expression of BAK1 protein |
CTD |
PMID:12530055 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of BAX protein] |
CTD |
PMID:19161993 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein] |
CTD |
PMID:19161993 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cat |
catalase |
multiple interactions |
ISO EXP |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased activity of CAT protein] perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of CAT protein] |
CTD |
PMID:19161993 PMID:20923693 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
perillyl alcohol results in decreased expression of CCNA2 protein |
CTD |
PMID:17138864 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
perillyl alcohol results in decreased expression of CCNB1 protein |
CTD |
PMID:17138864 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression multiple interactions |
ISO |
perillyl alcohol results in decreased expression of CDK2 protein perillyl alcohol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]; perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] |
CTD |
PMID:17138864 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases response to substance multiple interactions increases expression |
ISO |
CDKN1A protein results in increased susceptibility to perillyl alcohol perillyl alcohol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein] perillyl alcohol results in increased expression of CDKN1A protein |
CTD |
PMID:17138864 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression increases response to substance multiple interactions |
ISO |
perillyl alcohol results in increased expression of CDKN1B protein CDKN1B protein results in increased susceptibility to perillyl alcohol perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] |
CTD |
PMID:17138864 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Fbxo32 |
F-box protein 32 |
increases expression |
ISO |
perillyl alcohol results in increased expression of FBXO32 mRNA; perillyl alcohol results in increased expression of FBXO32 protein |
CTD |
PMID:19406843 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fnta |
farnesyltransferase, CAAX box, subunit alpha |
multiple interactions |
EXP |
[Vitamin A co-treated with perillyl alcohol] results in decreased expression of FNTA protein |
CTD |
PMID:15959631 |
|
NCBI chr16:66,065,131...66,083,460
Ensembl chr16:66,065,132...66,083,460
|
|
G |
Fntb |
farnesyltransferase, CAAX box, subunit beta |
multiple interactions increases expression decreases expression |
EXP |
[perillyl alcohol co-treated with Vitamin A] results in decreased expression of FNTB mRNA perillyl alcohol results in increased expression of FNTB protein perillyl alcohol results in decreased expression of FNTB mRNA |
CTD |
PMID:15959631 |
|
NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO EXP |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GSR protein] perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of GSR protein] |
CTD |
PMID:19161993 PMID:20923693 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
multiple interactions |
EXP |
perillyl alcohol inhibits the reaction [Ethanol results in decreased activity of H6PD protein] |
CTD |
PMID:20923693 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Ivl |
involucrin |
decreases expression |
ISO |
perillyl alcohol results in decreased expression of IVL protein |
CTD |
PMID:10769631 |
|
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19161993 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:19161993 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
multiple interactions |
ISO |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein] |
CTD |
PMID:19161993 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RAF1 protein] |
CTD |
PMID:19161993 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
multiple interactions increases expression |
ISO |
Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RAP1A protein] |
CTD |
PMID:12671036 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
perillyl alcohol inhibits the reaction [Ethanol results in increased activity of RELA protein] |
CTD |
PMID:20923693 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions increases expression |
ISO EXP |
Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RHOA protein] [perillyl alcohol co-treated with Vitamin A] results in increased expression of RHOA mRNA |
CTD |
PMID:12671036 PMID:15959631 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rhob |
ras homolog family member B |
multiple interactions increases expression |
ISO EXP |
Mevalonic Acid affects the reaction [perillyl alcohol results in increased expression of RHOB protein] perillyl alcohol results in increased expression of RHOB mRNA; perillyl alcohol results in increased expression of RHOB protein [perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB mRNA; [perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB protein |
CTD |
PMID:12671036 PMID:15959631 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
perillyl alcohol inhibits the reaction [Ethanol results in increased expression of TNF protein] |
CTD |
PMID:20923693 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Aatf |
apoptosis antagonizing transcription factor |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of AATF mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ACP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ACSS2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Adam18 |
ADAM metallopeptidase domain 18 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ADAM18 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:67,352,360...67,425,820
Ensembl chr16:67,352,416...67,425,248
|
|
G |
Adam3a |
ADAM metallopeptidase domain 3A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ADAM3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:67,299,949...67,349,970
Ensembl chr16:67,299,949...67,349,968
|
|
G |
Afg2a |
AFG2 AAA ATPase homolog A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of AFG2A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:120,306,417...120,497,707
Ensembl chr 2:120,306,412...120,497,705
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of AKT1 protein |
CTD |
PMID:25649747 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
increases expression |
ISO |
alpha phellandrene results in increased expression of ALDOC mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Ankrd49 |
ankyrin repeat domain 49 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ANKRD49 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:11,627,512...11,632,200
Ensembl chr 8:11,627,518...11,632,207
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ANXA1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa9 |
annexin A9 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ANXA9 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374
|
|
G |
Ap3m2 |
adaptor related protein complex 3 subunit mu 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of AP3M2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ARG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgef12 |
Rho guanine nucleotide exchange factor 12 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ARHGEF12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366
|
|
G |
Arsk |
arylsulfatase family, member K |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ARSK mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467
|
|
G |
Aspa |
aspartoacylase |
increases expression |
ISO |
alpha phellandrene results in increased expression of ASPA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ATF3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases phosphorylation |
ISO |
alpha phellandrene results in increased phosphorylation of BCL2 protein |
CTD |
PMID:25649747 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
increases phosphorylation |
ISO |
alpha phellandrene results in increased phosphorylation of BECN1 protein |
CTD |
PMID:25649747 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bmf |
Bcl2 modifying factor |
increases expression |
ISO |
alpha phellandrene results in increased expression of BMF mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of BNIP3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bod1 |
biorientation of chromosomes in cell division 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of BOD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:15,993,454...15,999,795
Ensembl chr10:15,993,454...15,999,787
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of BRCA1 protein |
CTD |
PMID:24861204 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of BTG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Calm2 |
calmodulin 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CALM2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
|
|
G |
Capns1 |
calpain, small subunit 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CAPNS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
|
|
G |
Caprin2 |
caprin family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CAPRIN2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830
|
|
G |
Card6 |
caspase recruitment domain family, member 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CARD6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:54,194,343...54,206,902
Ensembl chr 2:54,195,739...54,206,846
|
|
G |
Carhsp1 |
calcium regulated heat stable protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CARHSP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CCL5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccng2 |
cyclin G2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CCNG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CCRL2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Cd59b |
CD59b molecule |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CD59A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cdcp2 |
CUB domain containing protein 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CDCP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:121,877,581...121,894,203
Ensembl chr 5:121,877,581...121,894,203
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
alpha phellandrene results in increased expression of CDKN1A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
increases expression |
ISO |
alpha phellandrene results in increased expression of CDKN2D mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
alpha phellandrene results in increased expression of CFLAR mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLEC12A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Clec4d |
C-type lectin domain family 4, member D |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLEC4D mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
|
|
G |
Clec6a-ps1 |
C-type lectin domain family 6, member A, pseudogene 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLEC4N mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:156,539,408...156,559,032
Ensembl chr 4:156,539,408...156,558,605 Ensembl chr 4:156,539,408...156,558,605
|
|
G |
Cluh |
clustered mitochondria homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CLUH mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:59,509,580...59,531,345
Ensembl chr10:59,509,726...59,531,345
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CMPK2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cr1l |
complement C3b/C4b receptor 1 like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CR1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:106,606,952...106,660,442
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Crisp1 |
cysteine-rich secretory protein 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CRISP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:20,741,775...20,768,796
Ensembl chr 9:20,741,777...20,768,796
|
|
G |
Cst7 |
cystatin F |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CST7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
|
|
G |
Csta |
cystatin A |
increases expression |
ISO |
alpha phellandrene results in increased expression of STFA1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Ctsg |
cathepsin G |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CTSG mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CXCL10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyb561d2 |
cytochrome b561 family, member D2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CYB561D2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:108,213,201...108,215,778
Ensembl chr 8:108,213,205...108,215,759
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of CYFIP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of CYP51 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
|
|
G |
Dbx1 |
developing brain homeobox 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DBX1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:99,348,638...99,354,173
Ensembl chr 1:99,349,608...99,354,038
|
|
G |
Dctd |
dCMP deaminase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DCTD mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:44,066,952...44,098,654
Ensembl chr16:44,055,128...44,098,446
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DDIT4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddx31 |
DEAD-box helicase 31 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DDX31 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:12,172,829...12,238,392
Ensembl chr 3:12,172,836...12,238,873
|
|
G |
Ddx60 |
DEXD/H-box helicase 60 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DDX60 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
increases expression |
ISO |
alpha phellandrene results in increased expression of DFFB mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dgka |
diacylglycerol kinase, alpha |
increases expression |
ISO |
alpha phellandrene results in increased expression of DGKA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110
|
|
G |
Dhrs1 |
dehydrogenase/reductase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DHRS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838
|
|
G |
Dhx33 |
DEAH-box helicase 33 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DHX33 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:55,708,102...55,724,618
Ensembl chr10:55,705,756...55,724,567
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DHX58 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of DKC1 mRNA |
CTD |
PMID:25075043 |
|
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DUSP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DUSP6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of DYNLT3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of EGLN3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of EGR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of EIF5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
|
|
G |
Elac2 |
elaC ribonuclease Z 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ELAC2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ELOVL1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
|
|
G |
Elovl7 |
ELOVL fatty acid elongase 7 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ELOVL7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ENO2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Fbxo44 |
F-box protein 44 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FBXO44 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:158,583,363...158,592,510
Ensembl chr 5:158,583,366...158,592,363
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
increases expression |
ISO |
alpha phellandrene results in increased expression of FGGY mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
|
|
G |
Flvcr1 |
FLVCR choline and heme transporter 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FLVCR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:102,586,263...102,608,647
Ensembl chr13:102,586,257...102,608,661
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
alpha phellandrene results in increased expression of FOS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FOXO1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fpr1 |
formyl peptide receptor 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FPR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:58,747,246...58,756,559
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FTH1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of FTL1 mRNA; alpha phellandrene results in increased expression of FTL2-PS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Ftsj3 |
FtsJ RNA 2'-O-methyltransferase 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FTSJ3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:91,180,945...91,187,389
Ensembl chr10:91,180,696...91,187,397
|
|
G |
Fxn |
frataxin |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of FXN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
|
|
G |
Gabarap |
GABA type A receptor-associated protein |
increases expression |
ISO |
alpha phellandrene results in increased expression of GABARAP mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
alpha phellandrene results in increased expression of GADD45A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GAS5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gbp6 |
guanylate binding protein family member 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GBP6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
|
|
G |
Gnas |
GNAS complex locus |
increases expression |
ISO |
alpha phellandrene results in increased expression of GNAS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnl3 |
G protein nucleolar 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GNL3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:6,207,402...6,213,491
Ensembl chr16:6,207,402...6,213,392
|
|
G |
Gpr84 |
G protein-coupled receptor 84 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GPR84 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
|
|
G |
Greb1l |
GREB1 like retinoic acid receptor coactivator |
increases expression |
ISO |
alpha phellandrene results in increased expression of GREB1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:1,392,330...1,629,483
Ensembl chr18:1,392,725...1,628,067
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GRINA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GTDC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:28,766,640...29,161,668
Ensembl chr 3:28,766,645...29,162,271
|
|
G |
Gys1 |
glycogen synthase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of GYS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
|
|
G |
Gzmf |
granzyme F |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of GZME mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:30,005,361...30,018,649
Ensembl chr15:30,007,267...30,018,649
|
|
G |
H1f0 |
H1.0 linker histone |
increases expression |
ISO |
alpha phellandrene results in increased expression of H1F0 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
increases expression |
ISO |
alpha phellandrene results in increased expression of H1F2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
|
|
G |
H2bc18 |
H2B clustered histone 18 |
increases expression |
ISO |
alpha phellandrene results in increased expression of H2BC18 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529
|
|
G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HCAR2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504
|
|
G |
Heatr1 |
HEAT repeat containing 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of HEATR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
|
|
G |
Helz2 |
helicase with zinc finger 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HELZ2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Hgh1 |
HGH1 homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of BRP16 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:108,091,918...108,094,740
Ensembl chr 7:108,091,951...108,094,737
|
|
G |
Hilpda |
hypoxia inducible lipid droplet-associated |
increases expression |
ISO |
alpha phellandrene results in increased expression of HILPDA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
|
|
G |
Hivep3 |
HIVEP zinc finger 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HIVEP3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of HSPA2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of HSPA5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of HSPA8 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ID2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of IDI1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IFIH1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
|
|
G |
Ifnl3 |
interferon, lambda 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IFNL3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of IL2RA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il36g |
interleukin 36, gamma |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of IL36G mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
|
|
G |
Irf5 |
interferon regulatory factor 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IRF5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
|
|
G |
Irf7 |
interferon regulatory factor 7 |
increases expression |
ISO |
alpha phellandrene results in increased expression of IRF7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irgm |
immunity-related GTPase M |
increases expression |
ISO |
alpha phellandrene results in increased expression of IRGM2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Itgal |
integrin subunit alpha L |
increases expression |
ISO |
alpha phellandrene results in increased expression of ITGAL mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Jagn1 |
jagunal homolog 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of JAGN1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:146,591,577...146,596,287
Ensembl chr 4:146,591,510...146,596,288
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
alpha phellandrene results in increased expression of JUN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kank2 |
KN motif and ankyrin repeat domains 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of KANK2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900
|
|
G |
Kdm7a |
lysine demethylase 7A |
increases expression |
ISO |
alpha phellandrene results in increased expression of KDM7A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998
|
|
G |
Klhl24 |
kelch-like family member 24 |
increases expression |
ISO |
alpha phellandrene results in increased expression of KLHL24 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of LIMA1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Llgl2 |
LLGL scribble cell polarity complex component 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of LLGL2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:101,050,978...101,086,527
Ensembl chr10:101,051,408...101,086,525
|
|
G |
LOC120098677 |
small nucleolar RNA MBII-202 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD68 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr19:51,154,626...51,154,708
Ensembl chr19:51,154,626...51,154,708
|
|
G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
increases expression |
ISO |
alpha phellandrene results in increased expression of LPP mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
|
|
G |
Ltn1 |
listerin E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of LTN1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886
|
|
G |
Ly6h |
lymphocyte antigen 6 family member H |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of LY6C1 mRNA; alpha phellandrene results in decreased expression of LY6C2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:107,258,779...107,261,270
Ensembl chr 7:107,258,779...107,261,454
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MAP2K6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MAT2A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
|
|
G |
Mcemp1 |
mast cell-expressed membrane protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MCEMP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:1,721,781...1,727,350
Ensembl chr12:1,718,730...1,725,986
|
|
G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MDC1 protein |
CTD |
PMID:24861204 |
|
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
|
|
G |
Mdn1 |
midasin AAA ATPase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MDN1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332
|
|
G |
Med29 |
mediator complex subunit 29 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MED29 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
|
|
G |
Med31 |
mediator complex subunit 31 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MED31 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326
|
|
G |
Mgarp |
mitochondria-localized glutamic acid-rich protein |
increases expression |
ISO |
alpha phellandrene results in increased expression of MGARP mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
|
|
G |
Mgat2 |
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MGAT2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MGMT protein |
CTD |
PMID:24861204 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mindy2 |
MINDY lysine 48 deubiquitinase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MINDY2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453
|
|
G |
Mir375 |
microRNA 375 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MIR375 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985
|
|
G |
Mr1 |
major histocompatibility complex, class I-related |
increases expression |
ISO |
alpha phellandrene results in increased expression of MR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MRPL20 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
|
|
G |
Mrpl45 |
mitochondrial ribosomal protein L45 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MRPL45 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:82,308,650...82,320,474
Ensembl chr10:82,308,427...82,320,474
|
|
G |
Mrto4 |
MRT4 homolog, ribosome maturation factor |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MRTO4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:151,601,780...151,608,533
Ensembl chr 5:151,601,780...151,608,287
|
|
G |
Ms4a3 |
membrane spanning 4-domains A3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MS4A3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:208,462,300...208,480,129
Ensembl chr 1:208,462,301...208,480,101
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MTOR protein |
CTD |
PMID:25649747 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtx3 |
metaxin 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MTX3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:24,066,332...24,079,708
Ensembl chr 2:24,066,365...24,079,670
|
|
G |
Muc13 |
mucin 13, cell surface associated |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MUC13 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727
|
|
G |
Mx2 |
MX dynamin like GTPase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MX2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342
|
|
G |
Mxd1 |
max dimerization protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of MXD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Myadm |
myeloid-associated differentiation marker |
increases expression |
ISO |
alpha phellandrene results in increased expression of MYADM mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
|
|
G |
Mybbp1a |
MYB binding protein 1a |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of MYBBP1A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:57,056,897...57,067,258
Ensembl chr10:57,056,874...57,067,255
|
|
G |
Myo9a |
myosin IXA |
increases expression |
ISO |
alpha phellandrene results in increased expression of MYO9A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
increases expression |
ISO |
alpha phellandrene results in increased expression of NAMPT mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nat10 |
N-acetyltransferase 10 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NAT10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:90,111,643...90,149,891
Ensembl chr 3:90,111,645...90,149,927
|
|
G |
Ndrg2 |
NDRG family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of NDRG2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
increases expression |
ISO |
alpha phellandrene results in increased expression of NFIL3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases expression |
ISO |
alpha phellandrene results in increased expression of NFKBIA mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nhp2 |
NHP2 ribonucleoprotein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NHP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
|
|
G |
Nol10 |
nucleolar protein 10 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOL10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:40,144,217...40,225,353
Ensembl chr 6:40,144,235...40,225,353
|
|
G |
Nol8 |
nucleolar protein 8 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOL8 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848
|
|
G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOLC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088
|
|
G |
Nop2 |
NOP2 nucleolar protein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:157,932,731...157,944,462
Ensembl chr 4:157,932,716...157,944,459
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of NOP56 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of NOS2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nxt2 |
nuclear transport factor 2-like export factor 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of NXT2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:105,855,616...105,862,902
Ensembl chr X:105,855,608...105,862,899
|
|
G |
Oas1a |
2'-5' oligoadenylate synthetase 1A |
increases expression |
ISO |
alpha phellandrene results in increased expression of OAS1A mRNA; alpha phellandrene results in increased expression of OAS1B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
|
|
G |
Oas3 |
2'-5'-oligoadenylate synthetase 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of OAS3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
|
|
G |
Osbpl9 |
oxysterol binding protein-like 9 |
increases expression |
ISO |
alpha phellandrene results in increased expression of OSBPL9 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196
|
|
G |
Pabir2 |
PABIR family member 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PABIR2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:132,989,124...133,015,625
Ensembl chr X:132,989,124...133,015,580
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PARP14 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Pcyox1l |
prenylcysteine oxidase 1 like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PCYOX1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
|
|
G |
Pde3b |
phosphodiesterase 3B |
increases expression |
ISO |
alpha phellandrene results in increased expression of PDE3B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334
|
|
G |
Phospho1 |
phosphoethanolamine/phosphocholine phosphatase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PHOSPHO1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
increases expression |
ISO |
alpha phellandrene results in increased expression of PIK3CB mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Pld4 |
phospholipase D family, member 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PLD4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376
|
|
G |
Plxdc1 |
plexin domain containing 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PLXDC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130
|
|
G |
Pnrc2 |
proline-rich nuclear receptor coactivator 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PNRC2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:148,103,966...148,106,950
Ensembl chr 5:148,095,699...148,107,242 Ensembl chr 5:148,095,699...148,107,242
|
|
G |
Polr1b |
RNA polymerase I subunit B |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of POLR1B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:116,333,910...116,358,385
Ensembl chr 3:116,333,889...116,358,379
|
|
G |
Pop1 |
POP1 homolog, ribonuclease P/MRP subunit |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of POP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141
|
|
G |
Ppan |
peter pan homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PPAN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PPAT mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144
|
|
G |
Ppm1k |
protein phosphatase, Mg2+/Mn2+ dependent, 1K |
increases expression |
ISO |
alpha phellandrene results in increased expression of PPM1K mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152
|
|
G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
increases expression |
ISO |
alpha phellandrene results in increased expression of PPP2R5C mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:129,461,689...129,598,344
Ensembl chr 6:129,461,648...129,598,346
|
|
G |
Pprc1 |
PPARG related coactivator 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PPRC1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PRKDC protein |
CTD |
PMID:24861204 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Prss1 |
serine protease 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TRY10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792
|
|
G |
Ptbp3 |
polypyrimidine tract binding protein 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of PTBP3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:74,313,367...74,399,439
Ensembl chr 5:74,315,101...74,399,791
|
|
G |
Ptpmt1 |
protein tyrosine phosphatase, mitochondrial 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PTPMT1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:76,889,922...76,899,427
Ensembl chr 3:76,889,922...76,899,427
|
|
G |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PTPN7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:46,570,904...46,584,048
Ensembl chr13:46,571,712...46,583,308
|
|
G |
Pus7 |
pseudouridine synthase 7 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PUS7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:11,360,169...11,401,139
Ensembl chr 4:11,360,188...11,401,172
|
|
G |
Pus7l |
pseudouridine synthase 7 like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of PUS7L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:125,659,507...125,706,582
Ensembl chr 7:125,659,507...125,682,333
|
|
G |
Rad51c |
RAD51 paralog C |
increases expression |
ISO |
alpha phellandrene results in increased expression of RAD51C mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248
|
|
G |
Rap2b |
RAP2B, member of RAS oncogene family |
increases expression |
ISO |
alpha phellandrene results in increased expression of RAP2B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:145,599,714...145,600,265
Ensembl chr 2:145,599,116...145,603,069
|
|
G |
Rbm12b |
RNA binding motif protein 12B |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RBM12B2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:25,597,405...25,610,324
Ensembl chr 5:25,590,493...25,611,245
|
|
G |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
increases expression |
ISO |
alpha phellandrene results in increased expression of RBPJ mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353
|
|
G |
Rcl1 |
RNA terminal phosphate cyclase-like 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RCL1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
|
|
G |
RGD1359108 |
similar to RIKEN cDNA 3110043O21 |
increases expression |
ISO |
alpha phellandrene results in increased expression of C9ORF72 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:49,766,340...49,791,434
Ensembl chr 5:49,766,325...49,791,408
|
|
G |
Rhobtb2 |
Rho-related BTB domain containing 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RHOBTB2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:44,868,251...44,888,436
Ensembl chr15:44,870,376...44,888,651
|
|
G |
Rig1 |
RNA sensor RIG-1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RIGI mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
|
|
G |
rnf141 |
ring finger protein 141 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RNF141 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:164,933,972...164,957,081
Ensembl chr 1:164,931,077...164,957,118
|
|
G |
Rnf19b |
ring finger protein 19B |
increases expression |
ISO |
alpha phellandrene results in increased expression of RNF19B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
|
|
G |
Rp2 |
RP2 activator of ARL3 GTPase |
increases expression |
ISO |
alpha phellandrene results in increased expression of RP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688
|
|
G |
Rpp14 |
ribonuclease P/MRP subunit p14 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RPP14 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:16,837,796...16,847,970
Ensembl chr15:16,836,859...16,852,101 Ensembl chr15:16,836,859...16,852,101
|
|
G |
Rpp38 |
ribonuclease P/MRP subunit p38 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RPP38 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:74,914,066...74,917,742
Ensembl chr17:74,908,932...74,927,431
|
|
G |
Rps12 |
ribosomal protein S12 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RPS12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
|
|
G |
Rras |
RAS related |
increases expression |
ISO |
alpha phellandrene results in increased expression of RRAS mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
|
|
G |
Rrp12 |
ribosomal RNA processing 12 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RRP12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:240,672,378...240,705,992
Ensembl chr 1:240,672,382...240,706,018
|
|
G |
Rrp15 |
ribosomal RNA processing 15 homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RRP15 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr13:98,276,276...98,299,357
Ensembl chr13:98,276,134...98,299,370
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RSAD2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Rtl1 |
retrotransposon-like 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of RTL1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:128,543,904...128,549,384
Ensembl chr 6:128,543,939...128,549,182
|
|
G |
Rtl8a |
retrotransposon Gag like 8A |
increases expression |
ISO |
alpha phellandrene results in increased expression of RTL8A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240
|
|
G |
Rtp4 |
receptor (chemosensory) transporter protein 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of RTP4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
|
|
G |
Rubcnl |
rubicon like autophagy enhancer |
increases expression |
ISO |
alpha phellandrene results in increased expression of RUBCNL mRNA |
CTD |
PMID:25075043 |
|
NCBI chr15:50,332,458...50,377,494
Ensembl chr15:50,332,418...50,400,849
|
|
G |
Samhd1 |
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SAMHD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SAT1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Sdad1 |
SDA1 domain containing 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SDAD1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:15,741,489...15,768,271
Ensembl chr14:15,741,434...15,771,066
|
|
G |
Sec14l1 |
SEC14-like lipid binding 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SEC14L1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
|
|
G |
Selenbp1 |
selenium binding protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SELENBP1 mRNA; alpha phellandrene results in increased expression of SELENBP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
G |
Sema3c |
semaphorin 3C |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SEMA3C mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
|
|
G |
Senp2 |
SUMO specific peptidase 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SENP2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238
|
|
G |
Septin8 |
septin 8 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SEPT8 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:37,684,649...37,713,704
Ensembl chr10:37,684,639...37,713,174
|
|
G |
Sertad3 |
SERTA domain containing 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SERTAD3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001
|
|
G |
Set |
Set nuclear proto-oncogene |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SET mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
alpha phellandrene results in increased expression of SFN protein |
CTD |
PMID:24861204 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sgf29 |
SAGA complex associated factor 29 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SGF29 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:181,238,458...181,271,931
Ensembl chr 1:181,238,468...181,274,781
|
|
G |
Sgo2 |
shugoshin 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SGO2A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SIGMAR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc35b1 |
solute carrier family 35, member B1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC35B1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274
|
|
G |
Slc35d1 |
solute carrier family 35 member D1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC35D1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:117,928,628...117,981,289
Ensembl chr 5:117,934,352...117,981,311
|
|
G |
Slc44a1 |
solute carrier family 44 member 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SLC44A1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:68,061,941...68,241,912
Ensembl chr 5:68,063,618...68,241,909
|
|
G |
Slc44a3 |
solute carrier family 44, member 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SLC44A3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044
|
|
G |
Slc7a1 |
solute carrier family 7 member 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC7A1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC7A11 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a6 |
solute carrier family 7 member 6 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SLC7A6 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr19:34,073,472...34,100,268
Ensembl chr19:34,074,286...34,100,268
|
|
G |
Slfn5 |
schlafen family member 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SLFN4 mRNA; alpha phellandrene results in increased expression of SLFN5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
|
|
G |
Smim14 |
small integral membrane protein 14 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SMIM14 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760
|
|
G |
Smox |
spermine oxidase |
increases expression |
ISO |
alpha phellandrene results in increased expression of SMOX mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710 Ensembl chr X:118,731,900...118,765,710
|
|
G |
Snora20 |
small nucleolar RNA, H/ACA box 20 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA20 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:47,830,540...47,830,669
Ensembl chr 8:71,142,787...71,142,916
|
|
G |
Snora21 |
small nucleolar RNA, H/ACA box 21 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA21 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:82,775,114...82,775,249
Ensembl chr10:82,775,114...82,775,249
|
|
G |
Snora26 |
small nucleolar RNA, H/ACA box 26 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA26 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr14:34,127,640...34,127,760
Ensembl chr14:34,127,640...34,127,760
|
|
G |
Snora3A |
small nucleolar RNA, H/ACA box 3A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:163,540,664...163,540,793
Ensembl chr 1:163,540,664...163,540,793
|
|
G |
Snora44 |
small nucleolar RNA, H/ACA box 44 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA44 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:126,415,989...126,416,119
Ensembl chr 4:126,415,989...126,416,119
|
|
G |
Snora61 |
small nucleolar RNA, H/ACA box 61 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA61 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:144,506,420...144,506,549
Ensembl chr 5:144,506,420...144,506,549
|
|
G |
Snora73b |
small nucleolar RNA, H/ACA box 73b |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA73B mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:144,545,179...144,545,382
Ensembl chr 5:144,545,179...144,545,382
|
|
G |
Snora75 |
small nucleolar RNA, H/ACA box 75 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORA75 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:87,000,248...87,000,384
Ensembl chr 9:87,000,248...87,000,384
|
|
G |
Snord22 |
small nucleolar RNA, C/D box 22 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD22 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
|
|
G |
Snord34 |
small nucleolar RNA, C/D box 34 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD34 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:115,045,817...115,045,883
Ensembl chr 8:115,045,817...115,045,883
|
|
G |
Snord52 |
small nucleolar RNA, C/D box 52 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD52 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:3,878,412...3,878,477
Ensembl chr20:3,878,412...3,878,477
|
|
G |
Snord82 |
small nucleolar RNA, C/D box 82 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD82 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:87,004,515...87,004,586
Ensembl chr 9:87,004,515...87,004,586
|
|
G |
Snord87 |
small nucleolar RNA, C/D box 87 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD87 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:9,297,489...9,297,573
Ensembl chr 5:9,297,489...9,297,573
|
|
G |
Snord95 |
small nucleolar RNA, C/D box 95 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD95 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:33,171,983...33,172,050
Ensembl chr10:33,171,983...33,172,050
|
|
G |
Snord96a |
small nucleolar RNA, C/D box 96A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNORD96A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:33,171,093...33,171,172
Ensembl chr10:33,171,093...33,171,172
|
|
G |
Snrpd2 |
small nuclear ribonucleoprotein D2 polypeptide |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SNRPD2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351 Ensembl chr20:78,798,377...78,803,351
|
|
G |
Sp100 |
SP100 nuclear antigen |
increases expression |
ISO |
alpha phellandrene results in increased expression of SP100 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
|
|
G |
Sp140 |
SP140 nuclear body protein |
increases expression |
ISO |
alpha phellandrene results in increased expression of SP140 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:86,224,472...86,274,724
Ensembl chr 9:86,224,513...86,274,542
|
|
G |
Spc25 |
SPC25 component of NDC80 kinetochore complex |
increases expression |
ISO |
alpha phellandrene results in increased expression of SPC25 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
|
|
G |
Spred3 |
sprouty-related, EVH1 domain containing 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of SPRED3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:84,458,779...84,470,425
Ensembl chr 1:84,459,314...84,470,249
|
|
G |
Sri |
sorcin |
increases expression |
ISO |
alpha phellandrene results in increased expression of SRI mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
|
|
G |
Srm |
spermidine synthase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SRM mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srr |
serine racemase |
increases expression |
ISO |
alpha phellandrene results in increased expression of SRR mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
|
|
G |
Srsf7 |
serine and arginine rich splicing factor 7 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SRSF7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
|
|
G |
Ssr4 |
signal sequence receptor subunit 4 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SSR4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:151,524,191...151,528,218
Ensembl chr X:151,524,009...151,528,202
|
|
G |
St8sia5 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ST8SIA5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr18:70,736,395...70,802,537
Ensembl chr18:70,736,602...70,797,789
|
|
G |
Stard3nl |
STARD3 N-terminal like |
increases expression |
ISO |
alpha phellandrene results in increased expression of STARD3NL mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:45,583,278...45,617,226
Ensembl chr17:45,583,266...45,617,226
|
|
G |
Stard5 |
StAR-related lipid transfer domain containing 5 |
increases expression |
ISO |
alpha phellandrene results in increased expression of STARD5 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:137,606,151...137,616,017
Ensembl chr 1:137,606,177...137,616,469
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of STAT1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of STAT2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
G |
Supv3l1 |
Suv3 like RNA helicase |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of SUPV3L1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:30,378,542...30,399,076
Ensembl chr20:30,378,550...30,399,054
|
|
G |
Taf1d |
TATA-box binding protein associated factor, RNA polymerase I subunit D |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TAF1D mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TBXAS1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
|
|
G |
Tceanc |
transcription elongation factor A N-terminal and central domain containing |
increases expression |
ISO |
alpha phellandrene results in increased expression of TCEANC mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:27,952,539...27,961,038
Ensembl chr X:27,952,457...27,960,940
|
|
G |
Tcp11l2 |
t-complex 11 like 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TCP11L2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095
|
|
G |
Tctn3 |
tectonic family member 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TCTN3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:239,414,003...239,425,273
Ensembl chr 1:239,415,203...239,425,272
|
|
G |
Tdrd7 |
tudor domain containing 7 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TDRD7 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544
|
|
G |
Tepsin |
TEPSIN, adaptor related protein complex 4 accessory protein |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TEPSIN mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:105,373,939...105,381,310
Ensembl chr10:105,373,941...105,382,266
|
|
G |
Tesk2 |
testis associated actin remodelling kinase 2 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TESK2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:130,178,715...130,270,594
Ensembl chr 5:130,185,033...130,271,292
|
|
G |
Tfap4 |
transcription factor AP-4 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TFAP4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:11,001,338...11,019,386
Ensembl chr10:11,002,911...11,019,386
|
|
G |
Thg1l |
tRNA-histidine guanylyltransferase 1-like |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of THG1L mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:30,387,929...30,396,579
Ensembl chr10:30,387,940...30,396,687
|
|
G |
Timm10 |
translocase of inner mitochondrial membrane 10 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TIMM10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940
|
|
G |
Tmem120a |
transmembrane protein 120A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TMEM120A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr12:20,942,243...20,950,908
Ensembl chr12:20,942,439...20,990,316
|
|
G |
Tmem97 |
transmembrane protein 97 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TMEM97 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
|
|
G |
Tmsb10 |
thymosin, beta 10 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TMSB10 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
|
|
G |
Tmsb4x |
thymosin beta 4, X-linked |
increases expression |
ISO |
alpha phellandrene results in increased expression of TMSB4X mRNA |
CTD |
PMID:25075043 |
|
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667 Ensembl chr10:27,128,610...27,146,667
|
|
G |
Tp53 |
tumor protein p53 |
increases phosphorylation decreases expression affects localization increases expression |
ISO |
alpha phellandrene results in increased phosphorylation of TRP53 protein alpha phellandrene results in decreased expression of TRP53 protein alpha phellandrene affects the localization of TP53 protein alpha phellandrene results in increased expression of TRP53 protein modified form |
CTD |
PMID:24861204 PMID:25649747 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpd52 |
tumor protein D52 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TPD52 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622
|
|
G |
Tpm4 |
tropomyosin 4 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TPM4 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
|
|
G |
Trim21 |
tripartite motif-containing 21 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TRIM21 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440
|
|
G |
Tspoap1 |
TSPO associated protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TSPOAP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
|
|
G |
Tsr1 |
TSR1, ribosome maturation factor |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TSR1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864
|
|
G |
Tstd3 |
thiosulfate sulfurtransferase like domain containing 3 |
increases expression |
ISO |
alpha phellandrene results in increased expression of TSTD3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 5:35,294,652...35,304,093
Ensembl chr 5:35,294,645...35,304,101
|
|
G |
Ttc27 |
tetratricopeptide repeat domain 27 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of TTC27 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 6:20,558,756...20,702,126
Ensembl chr 6:20,558,756...20,702,115
|
|
G |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of UBASH3A mRNA |
CTD |
PMID:25075043 |
|
NCBI chr20:9,291,471...9,334,685
Ensembl chr20:9,292,139...9,329,224
|
|
G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
increases expression |
ISO |
alpha phellandrene results in increased expression of UBE2H mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:58,834,674...58,930,156
Ensembl chr 4:58,834,674...58,930,156
|
|
G |
Urb2 |
URB2 ribosome biogenesis homolog |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of URB2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr19:52,011,019...52,036,607
Ensembl chr19:52,011,112...52,036,597
|
|
G |
Usp18 |
ubiquitin specific peptidase 18 |
increases expression |
ISO |
alpha phellandrene results in increased expression of USP18 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
|
|
G |
Usp22 |
ubiquitin specific peptidase 22 |
increases expression |
ISO |
alpha phellandrene results in increased expression of USP22 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:45,828,619...45,855,468
Ensembl chr10:45,828,622...45,855,497
|
|
G |
Usp36 |
ubiquitin specific peptidase 36 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of USP36 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:103,497,349...103,528,877
Ensembl chr10:103,497,349...103,528,877
|
|
G |
Utp20 |
UTP20 small subunit processome component |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of UTP20 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 7:23,134,630...23,215,639
Ensembl chr 7:23,134,637...23,215,632
|
|
G |
Wdr12 |
WD repeat domain 12 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR12 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469
|
|
G |
Wdr3 |
WD repeat domain 3 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR3 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 2:187,505,816...187,528,432
Ensembl chr 2:187,505,816...187,528,432
|
|
G |
Wdr74 |
WD repeat domain 74 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR74 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:205,631,769...205,636,558
Ensembl chr 1:205,631,824...205,636,563
|
|
G |
Wdr75 |
WD repeat domain 75 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of WDR75 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 9:47,903,214...47,933,399
Ensembl chr 9:47,903,200...47,933,399
|
|
G |
Wdsub1 |
WD repeat, sterile alpha motif and U-box domain containing 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of WDSUB1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:44,340,415...44,370,890
Ensembl chr 3:44,340,415...44,370,891
|
|
G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of WIPI1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
|
|
G |
Xaf1 |
XIAP associated factor 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of XAF1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
|
|
G |
Yars2 |
tyrosyl-tRNA synthetase 2 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of YARS2 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr11:84,632,350...84,638,138
Ensembl chr11:84,624,369...84,638,125
|
|
G |
Zbp1 |
Z-DNA binding protein 1 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ZBP1 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870
|
|
G |
Zfp26 |
zinc finger protein 26 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ZFP882 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 8:18,959,656...18,985,647
Ensembl chr 8:18,965,271...18,988,325
|
|
G |
Zfp260 |
zinc finger protein 260 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ZFP260 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr 1:85,336,567...85,349,896
Ensembl chr 1:85,336,618...85,350,067
|
|
G |
Zfp346 |
zinc finger protein 346 |
decreases expression |
ISO |
alpha phellandrene results in decreased expression of ZFP346 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr17:9,493,787...9,523,681
Ensembl chr17:9,493,803...9,523,635
|
|
G |
Zfp39 |
zinc finger protein 39 |
increases expression |
ISO |
alpha phellandrene results in increased expression of ZFP719 mRNA |
CTD |
PMID:25075043 |
|
NCBI chr10:43,656,444...43,679,743
Ensembl chr10:43,656,444...43,679,743
|
|
|
G |
Clec10a |
C-type lectin domain containing 10A |
multiple interactions |
ISO |
carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased expression of CLEC10A mRNA] |
CTD |
PMID:37967808 |
|
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased expression of CLEC10A mRNA]; carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased expression of MRC1 mRNA]; carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:37967808 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
carveol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:37967808 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased expression of CLEC10A mRNA]; carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased expression of MRC1 mRNA]; carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:37967808 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
carveol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] |
CTD |
PMID:37967808 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
multiple interactions |
ISO |
carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased expression of MRC1 mRNA] |
CTD |
PMID:37967808 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
carveol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:37967808 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Rhob |
ras homolog family member B |
increases expression multiple interactions |
ISO |
carveol results in increased expression of RHOB protein Mevalonic Acid affects the reaction [carveol results in increased expression of RHOB protein] |
CTD |
PMID:12671036 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
multiple interactions |
ISO |
carveol promotes the reaction [[IL4 protein co-treated with IL13 protein] results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:37967808 |
|
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
carveol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] |
CTD |
PMID:37967808 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of carveol |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
limonene inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:29251412 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
[carvone co-treated with limonene] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:29191726 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
decreases expression |
EXP |
limonene results in decreased expression of AKR1D1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
|
|
G |
Alb |
albumin |
increases expression multiple interactions |
EXP |
limonene results in increased expression of ALB protein limonene inhibits the reaction [Carbon Tetrachloride results in decreased secretion of ALB protein] |
CTD |
PMID:23159986 PMID:29251412 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Arg1 |
arginase 1 |
increases expression |
EXP |
limonene results in increased expression of ARG1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
limonene results in increased expression of ATF3 mRNA |
CTD |
PMID:27965148 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
increases expression |
EXP |
limonene results in increased expression of ATP1A1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
limonene results in decreased expression of BCL2 protein |
CTD |
PMID:12921557 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
EXP |
limonene results in increased expression of CALM1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
limonene inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:29251412 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
EXP |
limonene results in increased expression of CCNG1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
EXP |
limonene results in increased expression of CDK1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
increases expression |
EXP |
limonene results in increased expression of COL3A1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
increases expression |
EXP |
limonene results in increased expression of COX4I1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
increases expression |
EXP |
limonene results in increased expression of COX5A mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cox6c |
cytochrome c oxidase subunit 6C |
decreases expression |
EXP |
limonene results in decreased expression of COX6C mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 7:67,129,265...67,142,001
Ensembl chr 7:67,111,024...67,141,963
|
|
G |
Ctsd |
cathepsin D |
multiple interactions increases expression |
ISO |
Fulvestrant inhibits the reaction [Limonene results in increased expression of CTSD mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cyb5a |
cytochrome b5 type A |
increases expression |
EXP |
limonene results in increased expression of CYB5A mRNA |
CTD |
PMID:12815608 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
EXP |
limonene results in increased expression of CYCS mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
limonene results in increased expression of CYP1A1 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases activity |
EXP |
limonene results in decreased activity of CYP2B1 protein |
CTD |
PMID:9242356 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b12 |
cytochrome P450, family 2, subfamily b, polypeptide 12 |
increases expression |
EXP |
limonene results in increased expression of CYP2B12 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Limonene inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] |
CTD |
PMID:18385293 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
multiple interactions |
ISO |
Limonene inhibits the reaction [Testosterone results in increased expression of CYP4F8 mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr 7:12,030,276...12,058,020
Ensembl chr 7:12,030,301...12,057,782
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression |
EXP |
limonene results in increased expression of CYP51 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
increases expression |
EXP |
limonene results in increased expression of DECR1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dnaja2 |
DnaJ heat shock protein family (Hsp40) member A2 |
increases expression |
EXP |
limonene results in increased expression of DNAJA2 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr19:21,497,792...21,516,904
Ensembl chr19:21,497,729...21,516,901
|
|
G |
Dut |
deoxyuridine triphosphatase |
increases expression |
EXP |
limonene results in increased expression of DUT mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
EXP |
limonene results in increased expression of GADD45A mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
limonene results in increased expression of GCLM mRNA |
CTD |
PMID:27965148 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
EXP |
limonene results in increased expression of GJB2 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Glo1 |
glyoxalase 1 |
multiple interactions |
ISO |
limonene inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] |
CTD |
PMID:28986142 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gna15 |
G protein subunit alpha 15 |
increases response to substance multiple interactions |
ISO |
GNA15 protein results in increased susceptibility to limonene [GNA15 protein results in increased susceptibility to Limonene] which results in increased activity of OR2V1 protein |
CTD |
PMID:9875846 |
|
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
EXP |
limonene results in increased expression of GPX1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases expression |
EXP |
limonene results in increased expression of GPX4 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
multiple interactions increases expression |
ISO |
Fulvestrant inhibits the reaction [Limonene results in increased expression of GREB1 mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Grpel1 |
GrpE-like 1, mitochondrial |
increases expression |
EXP |
limonene results in increased expression of GRPEL1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
EXP |
limonene results in increased expression of GSTM1 protein |
CTD |
PMID:23159986 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm5l |
glutathione S-transferase, mu 5-like |
increases expression |
EXP |
Limonene results in increased expression of GSTM5 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
limonene results in increased expression of HMOX1 mRNA limonene inhibits the reaction [Pyruvaldehyde results in decreased expression of HMOX1 protein] |
CTD |
PMID:20491607 PMID:28986142 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] |
CTD |
PMID:11802805 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
increases expression |
EXP |
limonene results in increased expression of HSP90AB1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
limonene results in increased expression of HSPD1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Il1a |
interleukin 1 alpha |
affects expression |
ISO |
Limonene affects the expression of IL1A protein |
CTD |
PMID:19878710 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
limonene inhibits the reaction [Pyruvaldehyde results in increased secretion of IL6 protein] |
CTD |
PMID:28986142 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
limonene inhibits the reaction [Diethylnitrosamine results in increased expression of JUN protein] |
CTD |
PMID:10425313 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
affects expression |
ISO |
Limonene affects the expression of LIF protein |
CTD |
PMID:19878710 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases expression |
EXP |
limonene results in increased expression of MAPK14 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk6 |
mitogen-activated protein kinase 6 |
increases expression |
EXP |
limonene results in increased expression of MAPK6 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 8:76,146,650...76,169,767
Ensembl chr 8:76,146,690...76,169,720
|
|
G |
Mgat2 |
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
increases expression |
EXP |
limonene results in increased expression of MGAT2 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions increases expression |
ISO EXP |
limonene inhibits the reaction [Diethylnitrosamine results in increased expression of MYC protein] limonene results in increased expression of MYC mRNA |
CTD |
PMID:10425313 PMID:12815608 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression |
EXP |
limonene results in increased expression of NFKB1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Npy |
neuropeptide Y |
decreases expression |
ISO EXP |
limonene results in decreased expression of NPY protein limonene results in decreased expression of NPY mRNA |
CTD |
PMID:22757684 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Obp3 |
alpha-2u globulin PGCL4 |
affects binding increases expression |
EXP |
limonene binds to OBP3 protein limonene results in increased expression of OBP3 protein |
CTD |
PMID:19428932 PMID:20069279 |
|
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
|
|
G |
Or2v1 |
olfactory receptor family 2 subfamily V member 1 |
multiple interactions increases activity |
ISO |
[GNA15 protein results in increased susceptibility to Limonene] which results in increased activity of OR2V1 protein Limonene results in increased activity of OR2V1 protein |
CTD |
PMID:9875846 |
|
NCBI chr10:33,399,891...33,404,298
Ensembl chr10:33,398,913...33,404,401
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
EXP |
limonene results in increased expression of PCNA mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
increases expression |
EXP |
limonene results in increased expression of PDIA3 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pgr |
progesterone receptor |
multiple interactions increases expression |
ISO |
Fulvestrant inhibits the reaction [Limonene results in increased expression of PGR mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[limonene co-treated with Pyruvaldehyde] results in increased expression of PPARGC1A protein |
CTD |
PMID:28986142 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppia |
peptidylprolyl isomerase A |
increases expression |
EXP |
limonene results in increased expression of PPIA mRNA |
CTD |
PMID:12815608 |
|
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
|
|
G |
Ppib |
peptidylprolyl isomerase B |
increases expression |
EXP |
limonene results in increased expression of PPIB mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 8:66,603,877...66,609,734
Ensembl chr 8:66,603,861...66,630,428
|
|
G |
Rara |
retinoic acid receptor, alpha |
decreases expression |
EXP |
limonene results in decreased expression of RARA mRNA |
CTD |
PMID:12815608 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
limonene inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA protein] |
CTD |
PMID:29251412 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression |
EXP |
limonene results in increased expression of SCD1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scn5a |
sodium voltage-gated channel alpha subunit 5 |
multiple interactions |
ISO |
limonene inhibits the reaction [2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate results in increased activity of SCN5A protein] |
CTD |
PMID:29306026 |
|
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
|
|
G |
Sec14l2 |
SEC14-like lipid binding 2 |
multiple interactions |
ISO |
Limonene inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr14:78,973,805...78,998,480
Ensembl chr14:78,973,808...78,993,788
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression |
EXP |
limonene results in decreased expression of SOD1 mRNA |
CTD |
PMID:12815608 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Tgfa |
transforming growth factor alpha |
increases expression |
EXP |
limonene results in increased expression of TGFA mRNA |
CTD |
PMID:12815608 |
|